Metal-organic frameworks (MOFs) with high surface areas and uniform microporous structures have shown potential application in many fields. Here we report a facial strategy to synthesize Fe2O3@NiCo2O4 porous nanocages by annealing core-shell Co3[Fe(CN)6]2@Ni3[Co(CN)6]2 nanocubes in air. The obtained samples have been systematically characterized by XRD, SEM, TEM and N2 adsorption-desorption analysis. The results show that the Fe2O3@NiCo2O4 porous nanocages have an average diameter of 213 nm and a shell thickness of about 30 nm. As anode materials for Li-ion batteries, the Fe2O3@NiCo2O4 porous nanocages exhibit a high initial discharge capacity of 1311.4 mA h g(-1) at a current density of 100 mA g(-1) (about 0.1 C). The capacity is retained at 1079.6 mA h g(-1) after 100 cycles. The synergistic effect of the different components and the porous hollow structure contributes to the outstanding performance of the composite electrode.

Purpose: The expression of LIM and SH3 protein 1 (LASP1) was upregulated in colorectal cancer cases, thereby contributing to the aggressive phenotypes of colorectal cancer cells. However, we still cannot decipher the underlying molecular mechanism associated with colorectal cancer metastasis.Experimental Design: In this study, IHC was performed to investigate the expression of proteins in human colorectal cancer tissues. Western blot analysis was used to assess the LASP1-induced signal pathway. Two-dimensional difference gel electrophoresis was performed to screen LASP1-modulated proteins and uncover the molecular mechanism of LASP1. TGFb was used to induce an epithelial-mesenchymal transition (EMT).Results: LASP1 expression was correlated with the mesenchymal marker vimentin and was inversely correlated with epithelial markers, namely, E-cadherin and b-catenin, in clinical colorectal cancer samples. The gain-and loss-of-function assay showed that LASP1 induces EMT-like phenotypes in vitro and in vivo. S100A4, identified as a LASP1-modulated protein, was upregulated by LASP1. Moreover, it is frequently coexpressed with LASP1 in colorectal cancer. S100A4 was required for EMT, and an increased cell invasiveness of colorectal cancer cell is induced by LASP1. Furthermore, the stimulation of TGFb resulted in an activated Smad pathway that increased the expression of LASP1 and S100A4. The depletion of LASP1 or S100A4 expression inhibited the TGFb signaling pathway. Moreover, it significantly weakened the proinvasive effects of TGFb on colorectal cancer cells.Conclusion: These findings elucidate the central role of LASP1 in the TGFb-mediated EMT process and suggest a potential target for the clinical intervention in patients with advanced colorectal cancer. Clin Cancer Res; 20(22); 5835-47. Ó2014 AACR.

Insulin-induced gene (Insig) negatively regulates SREBP-mediated de novo fatty acid synthesis in the liver. However, the upstream regulation of Insig is incompletely understood. Here we report that AMPK interacts with and mediates phosphorylation of Insig. Thr222 phosphorylation following AMPK activation is required for protein stabilization of Insig-1, inhibition of cleavage and processing of SREBP-1, and lipogenic gene expression in response to metformin or A769662. AMPK-dependent phosphorylation ablates Insig’s interaction with E3 ubiquitin ligase gp78 and represses its ubiquitination and degradation, whereas AMPK deficiency shows opposite effects. Interestingly, activation of AMPK by metformin causes an augmentation of Insig stability and reduction of lipogenic gene expression, and leads to the attenuation of hepatic steatosis in HFHS diet-fed mice. Moreover, hepatic overexpression of Insig-1 rescues hepatic steatosis in liver-specific AMPKα2 knockout mice fed with HFHS diet. These findings uncover a novel effector of AMPK. Targeting Insig may have the therapeutic potential for treating fatty liver disease and related disorders.